Nanjing Daily reported on the recent research progress of our college. The report highlighted that Professor Hui Wei’s team at the College of Engineering and Applied Sciences (CEAS), Nanjing University, is actively advancing the preclinical and commercialization efforts for nanozyme-enhanced prostheses. Their goal is to bring scientific achievements from the laboratory to the marketplace, facilitating the transformation “from 1 to 10.” According to Dr. Wei, nanozymes are a "treasure trove" worth exploring. In recent years, his team has focused on nanozyme design and applications, obtaining over ten patents in areas such as high-performance nanozyme fabrication, bioassays, and disease treatment. Among these, the invention patent for "Bone Implant Materials Modified with Nanozyme Drugs: Their Preparation Methods and Applications" has been approved. Dr. Wei explained that, addressing the issue of aseptic loosening in existing implants, they have collaborated with physicians to develop a nanozyme-enhanced implant. “This implant can inhibit bone resorption and promote bone formation, enabling bioinert implants to regulate bone metabolism. This offers a more effective approach to prevent and treat revisions after prosthetic replacement surgery.”
